Cold

Enzymatica will have a turnover of SEK 600 million by 2026

Enzymatica's report for the third quarter reported lower sales compared to the same period last year, a sales loss that...

Approved patent strengthens Enzymatica's position in Japan

At the end of last week, Enzymatica announced that...

Enzymatica and STADA extend agreement for ViruProtect

Enzymatica and STADA have had a long-standing...

Enzymatica's COO comments on this year's successes

Enzymatica has lined up many positive messages during...

New study data further strengthens Enzymatica's case

Once again, Enzymatica can report positive data with the cold spray...

Fully recruited study gives wind in the sails for Enzymatica

Enzymatica recently reported that the company's placebo-controlled, double-blind, multicenter study...